Blood sugar high above usual levels was linked to higher 30- and 90-day death risk in intensive care patients with sudden kidney injury. Researchers reviewed records from 5,555 people with sudden kidney injury in intensive care. They compared blood sugar at admission with Estimated Average Glucose (eAG). This estimate reflects roughly three months of blood sugar levels. It comes from HbA1c (Hemoglobin A1c), a blood test that tracks longer-term blood sugar. The researchers divided the admission reading by the longer-term estimate. This showed how high or low someone's reading was compared with their usual level. They then split people into four groups based on that comparison. The pattern formed a U shape: risk was higher at both ends. Higher values were clearly linked to more deaths within 30 and 90 days. The source does not give an exact percentage increase in risk. Researchers also tested 12 computer models to predict death within 30 days. Their best model performed better than standard intensive care scoring tools. The key point is context, not a new home target. This study looked at severe illness, not everyday blood sugar changes. It also cannot show that changing this comparison would prevent deaths. For BioSocial members, the useful distinction is between a single reading and a longer-term average. When sharing bloodwork, noting whether a test happened during illness can add context. Comparing notes with the community can help keep those different time frames clear. What differences have you noticed between your blood sugar readings during illness and your longer-term average?